14(top 5%)
papers
196(top 5%)
citations
6(top 5%)
h-index
13(top 5%)
g-index
14
all documents
211
doc citations
142
citing journals

Top Articles

#TitleJournalYearCitations
1Treatment with the novel anti-angiogenic agent PI-88 is associated with immune-mediated thrombocytopeniaAnnals of Oncology200256
2A comparison of bedside renal function estimates and measured glomerular filtration rate (Tc99mDTPA clearance) incancer patientsAnnals of Oncology200253
3Good clinical response to alectinib, a second generation ALK inhibitor, in refractory neuroblastomaPediatric Blood and Cancer201828
4Identification of an excellent prognosis subset of human papillomavirus-associated oropharyngeal cancer patients by quantification of intratumoral CD103+ immune cell abundanceAnnals of Oncology201925
5Validation and characterisation of prognostically significant PD-L1+ immune cells in HPV+ oropharyngeal squamous cell carcinomaOral Oncology202017
6Co-design and development of online video resources about immunotherapy with patients and their familyPatient Education and Counseling20217
7Evolving Landscape of Metastatic Cancer Survivorship: Reconsidering Clinical Care, Policy, and Research Priorities for the Modern EraJournal of Clinical Oncology20237
8Controversies in the management of gastrointestinal stromal tumorsAsia-Pacific Journal of Clinical Oncology20146
9First reported case of endometrial carcinoma in association with HIV infectionInternational Journal of Gynecological Cancer19993
10Direct access colonoscopy: impact of intervention on time to colorectal cancer diagnosis and treatment in North West TasmaniaInternal Medicine Journal20173
11Have centralised ethics and governance applications improved the time‐variable, and approval process to conduct research in Victorian hospitals?Internal Medicine Journal20193
12Poor prognosis germ-cell tumors: An unresolved challengeUrologic Oncology20022
13Pilot Study of Oral Eniluracil/5-FU in the Palliation of Hormone-Refractory Prostate CancerProstate Journal20011
14Is there a role for combined anti–PD‐1/CTLA‐4 checkpoint blockade in the management of advanced biliary tract cancers?Cancer20230